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Summary.-To evaluate cytotoxic function mediated by killer lymphocytes and
macrophages in urological cancer patients, we examined antibody-dependent and
spontaneous lympholysis of chicken erythrocyte target cells, which is mediated by
macrophages. Our results demonstrate a discordance between cytotoxic mechanisms
in cancer patients, killer-cell function being impaired whilst macrophage-mediated
cytotoxicity was increased.
RECENT STUDIES show that there are
subpopulations of human lymphoid cells
that are cytotoxic in vitro without prior
sensitization to various target cells, in-
cluding tumour cells (Perlmann etal., 1975;
Pross & Baines, 1977). Cytotoxicity by
unsensitized lymphoid cells is greatly
enhanced when target cells are coated with
specific antibody (Perlmann et al., 1975).
This cytotoxic phenomenon is called anti-
body-dependent cell-mediated cytotoxi-
city or antibody-dependent lympholysis
(ADCC). Cells that mediate ADCC have
been operationally defined as killer cells
(Perlmann et al., 1975; Brier et al., 1975).
It has been demonstrated that various
types of effector cells can mediate ADCC
depending upon the type of target cell.
For example, antibody-coated chicken
erythrocyte targets are susceptible to
lysis by granulocytes, macrophages, and
killer cells (MacDonald et al., 1975) whilst
antibody-coated Chang human liver cells
(Nelson et al., 1976) and many tumour-cell
lines (O'Toole et al., 1977) are susceptible
to lysis only by killer cells.
Unsensitized lymphocytes are also cap-
able of lysing target cells that are not
coated with antibody, a process which
will be referred to here as spontanieous
lympholysis (Pross & Baines, 1976). As
with ADCC, different types of effector
cells are active in mediating spontaneous
lympholysis, depending on the type of
target cell. For example, macrophages can
effect spontaneous lympholysis against
chicken erythrocytes (Mantovani et al.,
1972) whereas in humans lymphocytes
with surface properties similar to killer
cells mediate spontaneous lympholysis
against Chang cells (Cooper et al., 1977)
and many tumour cells (Pape et al., 1977).
Little is known about the in vivo rele-
vance of ADCC or spontaneous lympho-
lysis in humans. ADCC has been shown by
Hakala et al. (1974) to be operative in
some patients with transitional-cell car-
cinoma, and therefore may be of clinical
importance. Moreover, in animal tumour
systems, spontaneous lympholysis has
been postulated a natural cell-mediated
surveillance mechanism against oncogenic
viruses and tumour cells (Kiessling et al.,
1976; Herberman et al., 1975) and a similar
role has been postulated in humans (Pross
& Baines, 1977).
In the present study we have examined
simultaneously both ADCC and spon-
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taneous lympholysis against two target-
cell lines that are susceptible to lysis by
different types of effector cells in 41
patients with genitourinary cancer and 59
age-matched controls with benign uro-
logical conditions. Our results demonstrate
a discordance between cytotoxic mech-
anisms in cancer patients. Killer-cell-
mediated lysis and non-macrophage-
mediated spontaneous lympholysis were
diminished, and macrophage-mediated
cytotoxic mechanisms were markedly en-
hanced in comparison with controls.
PATIENTS
Ofthe 100 patients studied, 41 were cancer
patients (mean age 60.9) and 59 were controls
with benign urological conditions (mean age
55-5). Six cancer patients and 5 controls were
females. Patients receiving radiation or
chemotherapy are not included in this report.
Blood was drawn before major surgery in all
cases. In about one quarter of both cancer
patients and controls, blood was drawn
immediately after the induction of anaes-
thesia for diagnostic endoscopic procedures.
In many instances it was unknown whether
patients were controls or cancer patients until
after testing. Also, in many instances both
cancer patients and controls were tested
simultaneously. Thus, practical considera-
tions required that both cancer patients and
controls be studied randomly during the
period of this investigation. The histological
tumour types of the cancer patients are
shown in Table I.
TABLE I.-Cancer patients and controls
tested for ADCC and spontaneous and
antibody-dependent lympholysis
Patient group
Control (benign
urological
conditions)
Bladder carcinoma
Prostate carcinoma
Testis tumours
Renal carcinoma
Miscellaneous'
Total cancer
No. of Mean age
patients ± s.e.
59
13
18
4
3
3
41
55-5±2-2
62-7±3-6
66-1±1-4
34 3±3-0
61-3±5-4
60-3±5-3
60-9±1-5
1 2 colon carcinoma, 1 uterine carcinoma.
MATERIALS AND METHODS
We have previously reported most of the
methods used in this study (Catalona et al.,
1978). These methods will be referred to here
only briefly or by reference.
Effector cells.-Peripheral blood was drawn
into a syringe containing 500 u of preserva-
tive-free heparin and was diluted with an
equal volume of Hanks' balanced salt solu-
tion. Mononuclear cells were separated on a
Ficoll-Hypaque density gradient as described
by Boyum (1968) and were washed x 3 with
tissue-culture medium. This procedureyielded
99% viable mononuclear cells with less than
2% granulocyte contamination.
Target celts.-Two types of target cell
were used, chicken erythrocytes and Chang
human liver cells, both of which have been
well characterized for both spontaneous
and antibody-dependent lympholysis (Mac-
Donald et al., 1975; Nelson et al., 1976;
Mantovani et al., 1972; Cooper et al., 1977).
Target cells were labelled by incubating with
100 ,Ci or radioactive sodium dichromate for
60 min. Labelled target cells were washed and
resuspended in tissue-culture medium
(Catalona et al., 1978).
ADCC and spontaneous lympholysis assays.
-Chromium-labelled target cells were
pipetted into triplicate wells of microtitre
plates and incubated for 1 h with an appro-
priate dilution of an aniti-target-cell serum.
Serial dilutions of effector lymphocytes were
then added to the antibody-coated target
cells to give effector:target cell ratios of50:1,
25:1, 12:1, 6:1, 3:1 for Chang cells and 5:1,
2-5:1, 6:1, 3:1 for chicken erythrocytes. Con-
trol cultures were set up using targets that
were preincubated with normal rabbit serum
instead of anti-target-cell serum. Additional
controls included target cells alone (spon-
taneous release), target cells plus 4% cetri-
mide, a lysing detergent (maximal release),
target cells plus anti-target serum, and target
cells plus normal rabbit serum (Catalona et
al., 1978).
The microtitre plates were centrifuged and
then incubated in a 37°C, 5% CO2 incubator
for 18 h for chicken erythrocytes and 4 h for
Chang cells. The isotope released from target
cells into the supernatant was quantitated in
a gamma counter.
The following standard formulae (Cooper
et al., 1977) were used to calculate cyto-
toxicity:
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% ADCC=
experimental release by
release highest control
maximal release by
release highest control
% spontaneous=
release with release with normal lymphocytes and - r
normalrabbit serum rabbit serum only
maximal release with normal
release rabbit serum only ___
The coefficient of variation for replicate
samples from the same patient tested on the
same day (within-assay variability) was 014,
and the coefficient ofvariation for assays per-
formed on the same patient on different days
(between-assay variability) was 031.
Effector-cell fractionation.-To determine
which cells mediated ADCC and spon-
taneous lysis of our target cells, peripheral-
blood mononuclear cells were fractionated
(courtesy ofR. P. McDermott) by a modifica-
tion ofthe technique described by Brier et al.
(1975). Briefly, monocytes were removed by
passage over a Sephadex GIO column or by
glass adherence and subsequently removed.
Monocyte-depleted lymphocytes were incu-
bated at 370Cfor 1 hto removenonspecifically
absorbed immunoglobulin, and were then
passed over a Sephadex G-200 anti-human
(Fab')2 immunoadsorbent column. The T-
cell-enriched population thus obtained was
fractionated further by overnight sheep-
erythrocyte rosette formation, followed by
Ficoll-Hypaque density sedimentation. Non-
sheep-erythrocyte-rosette-forming cells (null
cells) at the interface were collected. T cells
in the B-cell population were removed by
overnight sheep-erythrocyte rosette forma-
tion at 40C followed by Ficoll-Hypaque
sedimentation. Fc receptor+ cells were iso-
lated by rosette formation with IgG-coated
sheep erythrocytes at 370C for 4 h followed
by Ficoll-Hypaque sedimentation. Interface
cells were collected as Fc receptor- cells.
Effector-cell marker proftles (Bean et al.,
1976).-We evaluated patient blood samples
for total and differential leucocyte counts.
We also evaluated the respective proportions
of mononuclear cells forming spontaneous
rosettes with sheep erythrocytes (T cells),
cells with demonstrable surface immuno-
globulin (B cells), cells forming rosettes with
IgG-coated sheep erythrocytes that had been
TABLE II.-ADCC and spontaneous lympholysis by peripheral-blood mononuclear cell
subpopulationsfrom a normal volunteer against chicken erythrocyte and Chang cells
Unfractionated
mononuclear cells
Macrophage-depleted
mononuclear cells
T+null
T (E+, Fc+)
T (E+, Fc-)
Surface Ig+
Null
Macrophage-enriched
Unfractionated
mononuclear cells4
Glass-nonadherent4
Glass-adherent4
0/ ADCC
lympholysis
Chicken
Eythro-
Chang' cyte2
37 49
33
33
30
15
2
66
18
ND
ND
ND
16
9
6
0
0
35
27
28
46
20
% Spontaneous
lympholysis
A
Chicken
Erythro-
Chang3 cyte
10 ND5
5
2
236
3
35
0
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
40
2
48
1 1-2 x 105 effector cells per 5 x 103 targets with a 4h incubation.
2 2-5 x 106 effector cells per 105 targets with a 4h incubation. The anti-chicken erythrocyte dilution used
was 10-3.
3 5 x 105 effector cells per 104 targets with a 36h incubation.
4 2-5 x 105 effector cells per 105 targets with an 18h incubation.
5 Not done.
6 T (E+, Fcl).
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previously coated with IgM antibody plus
complement (complement-receptor-bearing
lymphocytes) and cells phagocytosing latex
particles (macrophages).
Data analysis.-We plotted curves depict-
ing %0 cytotoxicity as a function of effector-
cell concentration. Differences in cytotoxicity
between patient groups were evaluated for
significance by Student's t test. We evaluated
correlations between assays by regression
analysis.
RESULTS
Effector cells mnediating ADCC and
spontaneous lympholysis
Fractionation profiles were performed
on cells obtained from 3 normal volunteers
on separate days. Although the absolute
lytic activity varied from donor to donor,
the relative lytic activity in each of the
fractions was comparable in all experi-
ments. A representative experiment is
shown in Table II. The results showed that
ADCC of Chang cells was mediated pri-
marily by nonphagocytic cells that lacked
surface immunoglobulin and many of
which lacked receptors for sheep erythro-
cytes, but expressed Fc receptors. These
data are consistent with previous reports
(Nelson et al., 1976) on killer-cell activity
against Chang cells. ADCC of chicken
erythrocytes was mediated by both killer
cells and macrophages, which is also in
accord with previous reports (MacDonald
et al., 1975).
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Spontaneous lympholysis of Chang cells
(Table II) was mediated by nonphagocytic
cells that lacked immunoglobulin, but
some of which had receptors for sheep
erythrocytes (West et al., 1978). On the
other hand, spontaneous lympholysis of
chicken erythrocytes was mediated pri-
marily by macrophages (Table II) (Man-
tovani et al., 1972).
Relationship between ADCC and
spontaneous lympholysis and age
Regression analysis revealed no correla-
tion between either ADCCT1 or spontaneous
ADCC and spontaneous lympholysis of
Chang cells
ADCC of Chang cells was depressed in
cancer patients (Fig. 1). This depression
was statistically significant (P<0.05) at
25:1 and 50:1 effector:target cell ratios and
in terms of peak cytotoxicity. Both blad-
der and prostate-cancer patients had peak
lytic levels that were significantly less than
the controls (Fig. 2). Interestingly,
patients with clinically localized tumours
showed a greater impairment of ADCC of
Chang cells than patients with metastases
(Fig. 3). However, not all patients studied
were surgically staged.
Spontaneous lympholysis of Chang cells
was also significantly depressed in cancer
patients (Fig. 4). Both prostate and
bladder-cancer patients had significant
impairments of spontaneous lysis at some
effector:target cell ratios; however, the
impairment was more pronounced in
prostate-cancer patients (Fig. 5). There
was no correlation between the impair-
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ment of spontaneous lympholysis and the
extent of the tumour involvement.
ADCC and spontaneous lympholysis of
chicken erythrocytes
We found no significant difference in
ADCC of chicken erythrocytes between
cancer patients and controls (Fig. 6).
Bladder-cancer patients showed stronger
lysis than either prostate-cancer patients
or controls, but the difference was not
statistically significant (Fig. 7). There was
also no correlation between ADCC of
chicken erythrocytes and tumour stage.
In contrast, we observed a highly sig-
nificant increase in spontaneous lympho-
lysis of chicken erythrocytes in cancer
patients (Fig. 8). This increase was signifi-
cant for both prostate and bladder-cancer
patients (Fig. 9), but there was no correla-
tion between tumour stage and spon-
taneous lysis of chicken erythrocytes.
Leucocyte counts and effector-cell
marker profiles
Cancer patients had a significantly
higher proportion oflatex-ingesting mono-
nuclear cells (macrophages) and lower
proportion of eosinophils than controls
(Table III). No significant differences in
3C
25
uJ
u
'U
U
-
uJ
U
IL- ad.
20
15
10
5
* Control N'59
* Cancer Nt40
* O<.Ol F
I
I A
.3 .6 1.2 2.5 5.0 Peak
Activity
EFFECTOR CELL x
1051105 CRBC TARGETS
FiGe. 8. Spontaneous lympholysis of chicken
erythrocytes in cancer patients and con-
trols.
7C
60
LU vv U)
ui -.A
Q 40
t 30
ui
u 20
0 .I
r 35
30
u, 25
'U
UJ 20
i-i Z. 15 z uJ U
LU 10
i Control PI.41
B Bladder Cancer NS8
P Prostate Cancer Na13
a P<<D5
.3 .6 1.2 2.5 5.0 Peak
Activity
EFFECTOR CELL x
1Q5/105 CRBC TARGETS
FIG. 7. ADCC of chicken erythrocytcs cells
in bladder or prostate carcinoma patients
anrd controls.
5
*-Control Nz59
B Bladder Cancer N'13
P Prostate Cancer N 17 '
* p<.05
I
l
.3 .6 1.2 2.5 5.0 Peak
Activity
EFFECTOR CELL x
105/105 CRBC TARGETS
Fic.. 9. Spontaneouis lympholysis of chicken
erythrocytes in bladdcer or prostate-
carcinoma patients an(l controls.
6'762
F
-
,
06 Ct A L
I -1 I 9 . I I I a . a ICELL-MEDIATED CYTOLYSIS IN UROLOGIC CANCER PATIENTS
TABLE III.-Effector-cell marker pro les
and leucocyte counts in cancer patients
and controls
Cell markers
E rosette+
EA rosette+
EAC rosette+
Phagocytose latex
Surface Ig+
Leucocyte
counts
WBC
PMN
Lymphocytes
Monocytes
Eosinophils
Basophils
Control
patients
39-3±2-5
7-3±0-8
6-9±0-8
14-5±1 0
12-0±1 1
Cancer
patients
40-7±2-8
8-4±0-7
6-1±0-8
18-3±1-6
13-4 1-6
Signifi-
cance1
NS2
NS
NS
P<005
NS
7,300±400 7,600±400 NS
62-8±1-5 65-9±1-8 NS
21-9±1-4 21-7±1-6 NS
9-8±0-7 10-9±1-3 NS
1-9±0-3 1-2±0-2 P<005
0-13±0-05 0-27±011 NS
1 Statistical analysis by Student's t test.
2 Not significant.
leucocyte counts or proportion of cells
forming rosettes with either sheep erythro-
cytes (T cells), IgG-coated sheep erythro-
cytes (Fc receptors), or IgM+ complement-
coated sheep erythrocytes (complement
receptor), or cells with surface Ig demon-
strable by immunofluorescence (B cells)
were noted.
DISCUSSION
Several limitations ofthis study deserve
mention. First, although we attempted to
study controls who were age-matched to
cancer patients, cancer patients were as a
group older (mean age 60.9) than controls
(mean age 55.5). However, we, like others
(Ting & Terasaki, 1974; Takasugi et al.,
1977), found no correlation between
ADCC or spontaneous lympholysis and
age in the control patients. Second, prac-
tical considerations dictate that in popu-
lation studies such as this, all patients
cannot be studied on the same day under
identical conditions. Thus, day-to-day
variation in the assay system (coefficient
of variation 0.31) could cause spurious
differences in cytotoxic functions. How-
ever, in a large group of patients and
controls studied randomly, day-to-day
variability of the assay should influence
controls and cancer patients equally. It is
also well known that anaesthesia and
surgery can impair cellular immune func-
tions. In the present study, about one-
quarter of both cancer patients and con-
trols had blood drawn after the induction
of light general anaesthesia for diagnostic
endoscopic procedures. In most of these
cases, it was not yet established whether
or not the patient had a malignancy. Thus,
anaesthetic effects should influence the
results of controls and cancer patients
equally.
Acknowledging these limitations, this
study demonstrates a discordance among
cell-mediated cytotoxic mechanisms in
urological cancer patients that is charac
terized by an impairment of both ADCC
and spontaneous lysis of Chang human
liver cells and a striking increase in spon-
taneous lympholysis of chicken erythro-
cytes. Our results suggest that this dis-
cordance may be due to differing levels of
activity in the respective effector cells that
mediate these different cytotoxic mech-
anisms. Both ADCC and spontaneous
lympholysis of Chang cells are mediated
by nonphagocytic cells that lack surface
Ig and lack or possess low-affinity sheep-
erythrocyte receptors, but have receptors
for the Fc portion of IgG(Brier et al.,
1975; West et al., 1978). These features
are characteristic of killer cells, and our
results in this respect are in accord with
those of previous studies (Nelson et al.,
1976; Cooper et al., 1977). In contrast,
ADCC ofchicken erythrocytes is mediated
by both killer cells and macrophages
(MacDonald et al., 1975). Taken together,
our cytotoxicity data indicate that killer-
cell activity is depressed whilst cytotoxic
macrophage function is enhanced in the
urologic cancer patients studied.
Previous reports on cell-mediated cyto-
toxic function in patients with solid
tumours are conflicting. Impairment of
both ADCC and spontaneous lympholysis
was reported by some (Stratton et al.,
1977; Ting & Terasaki, 1974; Takasugi
et al., 1973; Takasugi et al., 1977; Pross &
Baines, 1976), whilst others have reported
either no change (Peter et al., 1975;
Eremin et al., 1977) or selective enhance-
ment of spontaneous lympholysis against
certain target cells (Troye et al., 1977;
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Bolhuis, 1977; Moore & Robinson, 1977).
Our results are in accord with reports in
which only well-defined killer-cell effector-
cell functions were studied (Stratton,
1977; Pross & Baines, 1 976). Stratten et al.
(1977) using macrophage-depleted effector
cells against chicken erythrocyte targets,
observed a depression in killer-cell-
mediated ADCC in cancer patients. Also,
Pross & Baines (1976) reported depressed
spontaneous lympholysis in some cancer
patients using K562 target cells which are
known to be lysed only by lymphocytes
similar to killer cells. Although other
investigators found no change in ADCC or
spontaneous lympholysis in cancer
patients, the effector-cell functions oper-
ating in their assays were not well charac-
terized and may have included macro-
phage-mediated lytic mechanisms (Peter
et al., 1975; Eremin et al., 1977).
There have been reports of elevated
spontaneous lympholysis in cancer
patients in which the effector cells were
principally killer-cell-like lymphocytes. In
these reports, however, increased cyto-
toxicity was found only when bladder-
cancer cells were lysed by effector cells
from bladder-cancer patients, suggesting
that in these systems tumour-specific
mechanisms may have been operative
(Troye et al., 1977; Bolhuis, 1977; Moore
& Robinson, 1977). Based on our results,
it seems likely that the discrepancies that
have appeared in the literature may be
explained at least in part by differences in
effector-cell functions measured in the
cytotoxicity assays used.
In view of our demonstration of in-
creased cytotoxic macrophage activity in
cancer patients, it is relevant that the
expression of Fe receptors on macro-
phages was reported to be substantially
increased in cancer patients, but not in
patients with non-malignant conditions
(Rhodes, 1977). Although our results re-
vealed a statistically significant increase
in the proportion of circulating macro-
phages in cancer patients, we found no
evidence for an increased proportion of
Fe receptor-bearing cells.
Some previous studies have demon-
strated increased impairment of spon-
taneous lympholysis in patients with more
advanced tumours (Takasugi et al., 1977;
Pross & Baines, 1976) while other studies
(Ting & Terasaki, 1974) like our own,
have not found such a correlation. How-
ever, not all our patients were surgically
staged, and it is possible that some of our
patients were understaged.
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